(Q34748797)

4 August 2017

1 reference

title

T cell clonality and the effect of photopheresis in systemic sclerosis and graft versus host disease (English)

1 reference

4 August 2017

Lars E French

1

1 reference

4 August 2017

Alain H Rook

series ordinal

2

1 reference

4 August 2017

publication date

1 June 2002

1 reference

Transfusion and Apheresis Science

4 August 2017

published in

1 reference

4 August 2017

volume

26

1 reference

4 August 2017

issue

3

1 reference

4 August 2017

page(s)

191-196

1 reference

Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900012-5

7 January 2021

Photopheresis: clinical applications and mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900012-5

7 January 2021

Inhibition of autoimmune disease in a murine model of systemic lupus erythematosus induced by exposure to syngeneic photoinactivated lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900012-5

7 January 2021

Specific suppression of lupus-like graft-versus-host disease using extracorporeal photochemical attenuation of effector lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900012-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900012-5

1 reference

7 January 2021

A syndrome resembling progressive systemic sclerosis after bone marrow transplantation. A model for scleroderma?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900012-5

7 January 2021

New perspectives on the etiology of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900012-5

7 January 2021

Identification of clonal T cells in the blood of patients with systemic sclerosis: positive correlation with response to photopheresis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900012-5

7 January 2021

Graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900012-5

7 January 2021

Graft-versus-host disease: implications from basic immunology for prophylaxis and treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900012-5

7 January 2021

Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900012-5

7 January 2021

Clonal populations of T cells in normal elderly humans: the T cell equivalent to "benign monoclonal gammapathy".

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900012-5

7 January 2021

T cell receptor usage in autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900012-5

7 January 2021

Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900012-5

7 January 2021

Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900012-5

7 January 2021

Long-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900012-5

7 January 2021

Photopheresis therapy for cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900012-5

7 January 2021

Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900012-5

7 January 2021

Immunopathogenesis of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900012-5

7 January 2021

Co-localization of transforming growth factor beta 2 with alpha 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900012-5

7 January 2021

A possible role for transforming growth factor-beta in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900012-5

7 January 2021

10.1016/S1473-0502(02)00012-5

Identifiers

DOI

1 reference

4 August 2017

1 reference